General Newsletter
Issue
630
Eli Lilly to Pull Twitter Advertising after Fake Insulin Tweet; The State of Market Access in Denmark; Leadiant Faces Fines in Spain
Published Nov. 22, 2022
Sponsored Newsletter
Exclusive Whitepaper: Rare disease and real-world data: How RWD can help deliver better therapies and better outcomes
Published Nov. 21, 2022
Sponsored Newsletter
How to approach value-based care and precision medicine using RWD
Published Nov. 17, 2022
General Newsletter
Issue
629
US Democrats Eye High Drug Launch Prices; The State of US Healthcare with a Split Congress; WHO Releases Telemedicine Guide
Published Nov. 15, 2022
Sponsored Newsletter
THURSDAY | Streamlining Health Technology Assessments by Automating Literature Reviews
Published Nov. 14, 2022
Sponsored Newsletter
Live webinar on December 7th, sign up today!
Published Nov. 9, 2022
General Newsletter
Issue
628
India's Pharma Industry Strong Amid Inflation; ICER Revises Hemophilia Gene Therapy Report; FDA Discusses Pulse Oximeter Innaccuracies
Published Nov. 8, 2022
General Newsletter
Issue
626
Pfizer Eyes 400% Price Hike for COVID-19 Vaccine; FDA Opens PDUFA Applications; HHS Takes 340B Loss
Published Oct. 25, 2022
Sponsored Newsletter
NEXT WEEK | Achieving Consensus When Everyone is an Expert, but No One Agrees
Published Oct. 17, 2022
Sponsored Newsletter
Lumanity's Expanded Patient-Centered Outcomes Capabilities
Published Oct. 14, 2022
Sponsored Newsletter
REGISTER | Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Published Oct. 13, 2022
General Newsletter
Issue
624
Medicare Advantage Turnover Higher than Reported, US FTC Pulls the Stops on PBM Investigation; 1,200 Drug Prices Outstripped Inflation
Published Oct. 11, 2022
Sponsored Newsletter
UPCOMING | Achieving Consensus When Everyone is an Expert, but No One Agrees
Published Oct. 10, 2022
Sponsored Newsletter
Join STATinMED at Booth 510!
Published Oct. 6, 2022
Sponsored Newsletter
LIVE NEXT WEEK | Making HEOR More Accessible to Patients
Published Oct. 5, 2022
General Newsletter
Issue
623
Generics Companies Considering EU Cuts; Medicare 340B Brawl Drags On; Lecanemab May Skirt Aduhelm's CMS Fate
Published Oct. 4, 2022
Sponsored Newsletter
LIVE WEBINAR | Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Published Oct. 3, 2022
Sponsored Newsletter
New Webinar! Future direction of interactive tools for health technology assessment: LiveBIM, LiveOS, LiveUtility, & LiveCEM
Published Sep. 30, 2022
Sponsored Newsletter
Accelerate your RWE goals with Veradigm
Published Sep. 29, 2022
